Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium carbonate + cholecalciferol (MTI Medical)
- Development stage
- Phase 4
- Lead developer
- MTI Medical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zocobin Plus Tablet is a dietary supplement developed by MTI Medical, containing a combination of calcium carbonate (800mg) and vitamin D3 (cholecalciferol, 400IU). It is indicated for the prevention and treatment of calcium and vitamin D deficiencies, which are essential for maintaining bone density and preventing conditions such as osteoporosis. Calcium carbonate provides a source of elemental calcium necessary for bone mineralization, while vitamin D3 enhances the intestinal absorption of calcium and regulates calcium-phosphorus homeostasis. The product is marketed in an oral tablet formulation.
- Brand names
- Zocobin Plus Tablet
- Other names
- Zocobin Plus
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on calcium carbonate + cholecalciferol (MTI Medical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium carbonate + cholecalciferol (MTI Medical).